Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62

Benzinga Newsdesk www.benzinga.com Neutral 82.2%

Neg 0% Neu 82.2% Pos 0%

Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and announces Price Target of $62.